Circulating levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with severe head injury

Journal of Bone and Joint Surgery - Series B

Volumn 84, Issue 3, 2002, Pages 434-439

  Beeton, C A ^a   Brooks, R A ^a   Chatfield, D ^a   Human, M ^a   Rushton, N ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FRACTURE; FRACTURE HEALING; HEAD INJURY; HUMAN; MALE; OSTEOBLAST; PRIORITY JOURNAL; VOLUNTEER;

EID: 0036224925     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.84B3.12027     Document Type: Article

References (46)

1. Callus formation during diaphyseal fracture repair
2. Callus formation and the rate of healing of femoral fractures in patients with head injuries
3. The effect of head injury on fracture healing: A quantitative assessment
4. Accelerated fracture union in association with severe head injury
5. Bones in muscles: The problem of soft tissue ossification
6. Evidence for a humoral mechanism for enhanced osteogenesis after head injury
7. Sera from paraplegics with heterotopic ossification and patients with fractures and head injury stimulate human osteoblasts in vitro
8. Evaluation of serum osteoblast mitogenic activity in spinal cord and head injury patients with acute heterotopic ossification
9. Human fetal and adult chondrocytes: Effects of insulin and growth hormone on clonal growth
10. Interactions of growth factors present in bone matrix with bone cells: Effects on DNA synthesis and alkaline phosphatase
11. Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells
12. Insulin-like growth factors and their binding proteins: Biological actions
13. Growth hormone for the elderly?
14. Soluble 34K binding protein inhibits the binding of insulin-like growth factor-I to its cell receptors in human secretory endometrium: Evidence for autocrine/paracrine regulation of growth factor action
15. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-1
16. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: Effects of a pregnancy-associated serum protease activity
17. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy
18. Serum proteolysis of IGFBP-3
19. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind to IGFs inhibits the mitogenic effects of IGF-1 and insulin
20. Measurement and characterisation of insulin-like growth factor binding protein-3 in human biological fluids: Discrepancies between radioimmunoassay and ligand blotting
21. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulin-like growth factor-1
22. IGFBP-3 proteolysis by plasmin, thrombin, serum: Heparin binding, IGF binding and structure of fragments
23. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin binding protein: Its use for diagnosis of GH deficiency
24. Clinical utility of insulin-like growth factor assays
25. Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture
26. Growth hormone dependant stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I
27. Temporal structure of in vivo growth hormone secretory events in humans
28. Growth hormone and periarticular new bone formation: A causal relationship?: A preliminary communication
29. Endocrine abnormalities in severe traumatic brain injury: A clue to prognosis in severe cranio-cerebral trauma
30. Abbreviated injury scale and injury severity score: A scoring chart
31. Assessment of neurological signs
32. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies
33. Reduction of plasma immunoreactive somatomedin C during fasting in humans
34. Plasma somatomedin-C in fasted and refed rats: Close relationship with changes in liver somatogenic but not lactogenic binding sites
35. Growth hormone secretion in critical illness: Effect of dopamine
36. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-1
37. Anterior pituitary function during critical illness and dopamine treatment
38. Growth hormone and insulin-like growth factors in critical illness
39. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-3, IGFBP-3, IGFBP-6 and ALS) in blood circulation
40. Rapid bone loss is associated with increased levels of biochemical markers
41. Insulin-like growth factor Is and II: Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations
42. Insulin-like growth factors and bone: The osteoporosis connection
43. 24-hour secretion of growth hormone (GH), insulin-like growth factors-I and II (IGF-I, -II), prolactin (PRL) and thyrotropin (TSH) in young adults of normal and tall stature
44. Detection of serum insulin-like growth factor binding proteins on Western ligand blots by biotinylated IGF and enhanced chemiluminescence
45. Cloning and expression of human insulin-like growth factor binding protein-3
46. Insulinlike growth factor gene expression in human fracture callus